Covered recipient · General Payments record
TRISTAN BICE
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2021–2024
$2,724.30
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $386.43 | 5 |
| Education | $377.81 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $199.98 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $159.70 | 3 |
| E.R. Squibb & Sons, L.L.C. | $131.25 | 1 |
| Acerta Pharma LLC | $95.48 | 1 |
| SANOFI-AVENTIS U.S. LLC | $84.75 | 1 |
| AVEO Pharmaceuticals, Inc. | $74.99 | 1 |
| Merck Sharp & Dohme Corporation | $18.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $99.99 | 03/15/2024 | Education | Undisputed | 01/23/2026 | 1139345862 | CMS |
| Astellas Pharma US Inc | $99.99 | 03/15/2024 | Education | Undisputed | 01/23/2026 | 1139346656 | CMS |
| AstraZeneca Pharmaceuticals LP | $95.48 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105780372 | CMS |
| Aveo Pharmaceuticals, Inc. | $74.99 | 04/11/2024 | Education | Undisputed | 01/23/2026 | 1143487839 | CMS |
| Boston Scientific Corporation | $57.69 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092751802 | CMS |
| Boston Scientific Corporation | $9.70 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092751800 | CMS |
| Boston Scientific Corporation | $92.31 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092751804 | CMS |
| E.R. Squibb & Sons, L.L.C. | $131.25 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101276143 | CMS |
| Merck Sharp & Dohme LLC | $18.09 | 06/03/2024 | Education | Undisputed | 01/23/2026 | 1141824635 | CMS |
| SANOFI-AVENTIS U.S. LLC | $84.75 | 05/01/2024 | Education | Undisputed | 01/23/2026 | 1140008118 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.